Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SERTA domain containing 4B, pseudogene (SERTAD4BP) is classified as a human pseudogene, meaning it is a genomic DNA sequence similar to a gene but non-functional and not expressed as a protein[1][2][9]. There is no evidence supporting a role for this locus in coding functional proteins, serving as a therapeutic target, or involvement in biological pathways or disease phenotypes[1][2][9]. It is distinct from the related functional gene SERTA domain containing 4 (SERTAD4), which is protein-coding[5].\n\nKey clarifications:\n- This locus is not considered a therapeutic target (receptor, enzyme, transporter, etc.), and current scientific resources provide no therapeutic or disease relevance.\n- No known drugs, disease roles, or functional biomarkers are associated.\n- Its sole recognized alias is LINC00643, and official gene databases (HGNC, GeneCards) verify its status as a pseudogene[1][2][9].\n\nIf you were seeking a functional target related to the SERTAD4 family, consider SERTA domain containing 4 (SERTAD4), which is protein-coding and distinct from this pseudogene[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SERTA domain containing 4B, pseudogene (SERTAD4BP).